STANDARD BIOTLS (LAB)
(Delayed Data from NSDQ)
$1.32 USD
+0.02 (1.54%)
Updated Aug 4, 2025 04:00 PM ET
After-Market: $1.32 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
LAB 1.32 +0.02(1.54%)
Will LAB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LAB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LAB
Illumina Stock May Benefit From New Agreement to Acquire SomaLogic
Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates
LAB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Strength Seen in American Well (AMWL): Can Its 18.8% Jump Turn into More Strength?
Standard BioTools (LAB) Reports Q3 Loss, Tops Revenue Estimates
Other News for LAB
Mesa Laboratories: Strong Order Growth And Positive Valuation Outlook
FedEx Issues Soft Guidance, Joins Torrid Holdings, Allot And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Labrador Gold Strengthens Exploration Team with New VP Appointment
Labrador Gold appoints Ryan Weston as VP, exploration
U.S. strikes Iran nuclear sites, Novo terminates Hims & Hers deal: Morning Buzz